Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model

Weight loss due to skeletal muscle atrophy in patients with chronic pulmonary disease is negatively correlated with clinical outcome. Pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the dysregulated deposition of the extracellular matrix (ECM) with the dest...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiunn-Min Shieh, Hui-Yun Tseng, Fang Jung, Shih-Hsing Yang, Jau-Chen Lin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/7947596
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685427482525696
author Jiunn-Min Shieh
Hui-Yun Tseng
Fang Jung
Shih-Hsing Yang
Jau-Chen Lin
author_facet Jiunn-Min Shieh
Hui-Yun Tseng
Fang Jung
Shih-Hsing Yang
Jau-Chen Lin
author_sort Jiunn-Min Shieh
collection DOAJ
description Weight loss due to skeletal muscle atrophy in patients with chronic pulmonary disease is negatively correlated with clinical outcome. Pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the dysregulated deposition of the extracellular matrix (ECM) with the destruction of normal tissue, resulting in end-stage organ failure. BLM-induced fibrosis is one of several different experimental models of pulmonary fibrosis, characterized by inflammation and excessive ECM deposition. We directly induced mouse lung injury by the intratracheal administration of bleomycin and monitored the physiological and biochemical changes in lung and skeletal muscle tissues by using lung function testing, ELISA, Western blotting, and immunohistochemistry. Here, we found that BLM-induced lung fibrosis with thickened interstitial lung tissue, including fibronectin and collagen, was correlated with the increased serum concentrations of IL-6 and IL-33 and accompanied by reduced lung function, including FRC (functional residual capacity), C chord (lung compliance), IC (inspiratory capacity), VC (vital capacity), TLC (total lung capacity), and FVC (forced vital capacity) (p<0.05). The activity of AKT in lung tissue was suppressed, but conversely, the activity of STAT3 was enhanced during lung fibrosis in mice. In addition, we found that the amount of sST2, the soluble form of the IL-33 receptor, was dramatically decreased in lung fibrosis tissues. The skeletal muscle tissue isolated from lung injury mice increased the activation of STAT3 and AMPK, accompanied by an increased amount of Atrogin-1 protein in BLM-induced lung fibrosis mice. The mouse myoblast cell-based model showed that IL-6 and IL-33 specifically activated STAT3 and AMPK signaling, respectively, to induce the expression of the muscle-specific proteolysis markers MuRF1 and Atrogin-1. These data suggested that increased levels of IL-6 and IL-33 in the serum of mice with BLM-induced lung injury may cause lung fibrosis with thickened interstitial lung tissue accompanied by reduced lung function and muscle mass through the activation of STAT3 and AMPK signals.
format Article
id doaj-art-bf740c8b413f431d826c8a0102463206
institution DOAJ
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-bf740c8b413f431d826c8a01024632062025-08-20T03:23:08ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/79475967947596Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse ModelJiunn-Min Shieh0Hui-Yun Tseng1Fang Jung2Shih-Hsing Yang3Jau-Chen Lin4Division of Chest Medicine, Department of Internal Medicine, Chi Mei Medical Center, Yongkang, Tainan, TaiwanDepartment of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, TaiwanDepartment of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, TaiwanDepartment of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, TaiwanDepartment of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, TaiwanWeight loss due to skeletal muscle atrophy in patients with chronic pulmonary disease is negatively correlated with clinical outcome. Pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the dysregulated deposition of the extracellular matrix (ECM) with the destruction of normal tissue, resulting in end-stage organ failure. BLM-induced fibrosis is one of several different experimental models of pulmonary fibrosis, characterized by inflammation and excessive ECM deposition. We directly induced mouse lung injury by the intratracheal administration of bleomycin and monitored the physiological and biochemical changes in lung and skeletal muscle tissues by using lung function testing, ELISA, Western blotting, and immunohistochemistry. Here, we found that BLM-induced lung fibrosis with thickened interstitial lung tissue, including fibronectin and collagen, was correlated with the increased serum concentrations of IL-6 and IL-33 and accompanied by reduced lung function, including FRC (functional residual capacity), C chord (lung compliance), IC (inspiratory capacity), VC (vital capacity), TLC (total lung capacity), and FVC (forced vital capacity) (p<0.05). The activity of AKT in lung tissue was suppressed, but conversely, the activity of STAT3 was enhanced during lung fibrosis in mice. In addition, we found that the amount of sST2, the soluble form of the IL-33 receptor, was dramatically decreased in lung fibrosis tissues. The skeletal muscle tissue isolated from lung injury mice increased the activation of STAT3 and AMPK, accompanied by an increased amount of Atrogin-1 protein in BLM-induced lung fibrosis mice. The mouse myoblast cell-based model showed that IL-6 and IL-33 specifically activated STAT3 and AMPK signaling, respectively, to induce the expression of the muscle-specific proteolysis markers MuRF1 and Atrogin-1. These data suggested that increased levels of IL-6 and IL-33 in the serum of mice with BLM-induced lung injury may cause lung fibrosis with thickened interstitial lung tissue accompanied by reduced lung function and muscle mass through the activation of STAT3 and AMPK signals.http://dx.doi.org/10.1155/2019/7947596
spellingShingle Jiunn-Min Shieh
Hui-Yun Tseng
Fang Jung
Shih-Hsing Yang
Jau-Chen Lin
Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
Mediators of Inflammation
title Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
title_full Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
title_fullStr Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
title_full_unstemmed Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
title_short Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
title_sort elevation of il 6 and il 33 levels in serum associated with lung fibrosis and skeletal muscle wasting in a bleomycin induced lung injury mouse model
url http://dx.doi.org/10.1155/2019/7947596
work_keys_str_mv AT jiunnminshieh elevationofil6andil33levelsinserumassociatedwithlungfibrosisandskeletalmusclewastinginableomycininducedlunginjurymousemodel
AT huiyuntseng elevationofil6andil33levelsinserumassociatedwithlungfibrosisandskeletalmusclewastinginableomycininducedlunginjurymousemodel
AT fangjung elevationofil6andil33levelsinserumassociatedwithlungfibrosisandskeletalmusclewastinginableomycininducedlunginjurymousemodel
AT shihhsingyang elevationofil6andil33levelsinserumassociatedwithlungfibrosisandskeletalmusclewastinginableomycininducedlunginjurymousemodel
AT jauchenlin elevationofil6andil33levelsinserumassociatedwithlungfibrosisandskeletalmusclewastinginableomycininducedlunginjurymousemodel